Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Abstract submission deadline extended: International Pandemic Sciences Conference 2024

The deadline for abstract submissions and bursary applications for the International Pandemic Sciences Conference 2024 – Collaboration Beyond Boundaries has been extended to Monday 26 February 2024.

Students explore 'wicked problem' of pandemics

Students on the MSc International Health and Tropical Medicine programme discussed pandemics, during a day exploring some of the major challenges in global health, hosted by PSI's Dr Alice Norton.

New teaching collaboration with Brazilian universities

The University of Oxford has entered into an agreement with three Brazilian universities, to contribute to the delivery of an undergraduate course in ‘Translational Science’, starting in 2024. The course will teach the full journey of a product ‘from bench to bedside’ as part of any science degree to prepare the next generation of researchers for the translation of their laboratory discoveries into patient care and prevention.

FCDO Minister meets with University of Oxford’s vaccine researchers

The University of Oxford this week welcomed the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups.

Registration open for International Pandemic Sciences Conference 2024

PSI set to host international scientific conference in Oxford and online this July, to foster global research collaboration and prepare world for future pandemics.

Public health vision led by researchers from Oxford and Bangladesh aims to tackle Nipah virus

In a new paper published in The Lancet Infectious Diseases, researchers based in Bangladesh, Oxford and Geneva call for a comprehensive public health framework to counter Nipah virus and other neglected infectious diseases with pandemic potential.

Vaccine trial for deadly Nipah virus launched

Oxford-led UK trial is first step to developing a vaccine against Nipah virus – a devastating disease mostly found in South-East Asia.

New partnership aims to advance vaccine against MERS coronavirus

A partnership between CEPI, Barinthus Biotherapeutics and the University of Oxford aims to fast-track the development of a potential vaccine for the prevention of Middle East Respiratory Syndrome (MERS).

Study reveals that duration of exposure to COVID-19 plays major role in risk of catching the virus

Using data from 7 million people notified by the NHS COVID-19 contact tracing app, this is the first large-scale study to reveal how duration and proximity of contact with an infected person affects how COVID-19 is spread.

Nipah virus: How a neglected disease raises new ethical questions

New University of Oxford research brings to light important ethical considerations in Nipah virus outbreak control, its treatment, and research into vaccines.

Funders Roadmap is supporting better clinical trials

New framework helps funders to support coordinated, effective and equitable clinical trials in response to epidemics and pandemics.

Oxford receives £7.8 million to develop vaccines to fight epidemic and pandemic threats

New funding will support research into the prevention of five dangerous diseases with epidemic and pandemic potential.

Investment obtained by OxLEP helping to maintain vaccine development centre’s world-leading position

Critical investment secured by OxLEP has enabled the refurbishment of key areas of a major biomanufacturing facility in Oxford, supporting its status as a global leader.

Call for applications to establish networks of epidemic and pandemic sciences research excellence across Africa

PSI has joined forces with the Science for Africa Foundation and the Mastercard Foundation to launch a call for applications to establish innovative networks of research excellence in epidemic and pandemic sciences across Africa.

Oxford welcomes global pandemic experts for focus on 100 Days Mission

Scientific advisors to the International Pandemic Preparedness Secretariat (IPPS) visited the University of Oxford’s vaccine laboratories as part of a two-day meeting of the global coalition.

CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses

CEPI will provide up to $25 million to the University of Oxford to complete early development of prototype vaccines against the Junín virus, with a new project led by Professor Teresa Lambe.

World-leading RECOVERY trial expands to investigate treatments for influenza

The RECOVERY trial, the leading global clinical trial of treatments for COVID-19, has expanded to find effective treatments for patients hospitalised with flu.

Researchers analyse UK COVID-19 Infection Survey data to tell the story of the virus' genomic evolution and spread

Research published today brings together for the first time the epidemiology and evolution of the SARS-CoV-2 virus in the UK during the first three years of the pandemic – including how variants emerged and spread.

Conference brings together clinical researchers to explore lessons from COVID-19 for global research collaboration

Clinical researchers and representatives from the World Health Organization defined a bold new path for global research collaboration in acute care at a conference co-hosted by ISARIC, a global federation of investigator-led clinical research networks.

PSI seminar marks 25 years of Nipah virus

Over 60 researchers met this week to explore the latest research on deadly Nipah virus, including treatments, ethics and vaccines.

Load More